期刊文献+

睾酮对肝细胞胰岛素敏感性的影响及分子机制 被引量:2

Effects of testosterone on insulin sensitivity in liver cells and related molecular mechanisms
原文传递
导出
摘要 目的 探讨睾酮对肝细胞胰岛素敏感性的影响及分子机制.方法 在体实验:21只成年C57BL/6雌鼠根据体重按完全随机法分为睾酮组(11只)及对照组(10只),给药24周后处死.离体实验:将HepG2肝癌细胞分成3组:(1)10 9~10-5 mol/L睾酮处理0~36 h后胰岛素刺激;(2)101睾酮处理0~96 h后胰岛素刺激;(3)10-7 mol/L睾酮预处理36 h后胰岛素刺激,间隔4或6h后再次胰岛素刺激.Western印迹法检测鼠肝组织及HepG2细胞的蛋白激酶B(Akt)、糖原合成酶3β(GSK3β)活性及表达水平.结果 睾酮组鼠肝组织的Akt及GSK3β活性均明显低于对照组(分别为43.1%±3.2%比77.1% ±6.7%,14.7%±6.7%比82.3%±2.0%,均P<0.05).胰岛素单次刺激HepG2细胞时,10-8~10-6 mol/L睾酮处理36 h的Akt、GSK3β活性均显著高于对照组(均P<0.05);但当睾酮处理时间延长至96 h或浓度升高至10-5 mol/L时,Akt、GSK3β的活性转趋下降;10-7mol/L睾酮组预处理36 h后胰岛素间隔6h二次刺激时,睾酮组的Akt、GSK3β活性均显著低于对照组(均P<0.05).结论 睾酮先增强后抑制肝细胞的胰岛素信号通路的转导,可能导致肝脏的胰岛素敏感性先增强后抑制,甚至转变为胰岛素抵抗. Objective To explore the regulation of insulin sensitivity in liver cells by androgen signaling.Methods Eleven adult female C57BL/6 mice were injected daily with testosterone (group T) for 24 weeks.And 10 control mice received sesame oil only (group Con).HepG2 liver cells were initially pretreated with different doses of testosterone (10-9 _ 10-5 mol/L) for 0-36 h or with 10-7 mol/L testosterone for 0-96 h followed by a stimulation of 100 nmol/L insulin for 15 min.Later HepG2 cells were pretreated with 10-7 mol/L testosterone for 36 h followed by a stimulation of 100 nmol/L insulin for 15 min and then a restimulation of 100 nmol/L insulin for 15 min at 4 h and 6 h interval respectively.Phosphorylation and protein expression of Akt and GSK3β in C57BL/6 mice liver tissues and HepG2 cells were analyzed by Western blot.Results The 24-week treatment of testosterone decreased the phosphorylation of Akt and GSK3β in C57BL/6 adipose and liver tissues (43.1% _± 3.2% vs 77.1% __ 6.7%,14.7% __ 6.7% vs 82.3% _± 2.0% respectively,P 〈 0.05).Pretreatment with 10-8 _ 10-6 mol/L testosterone within 36 h obviously increased the phosphorylation of Akt and GSK3β (P 〈0.05).However pretreatment with 10-5 mol/L within 36 h or with 10-7 mol/L for 96 h had no effect on the phosphorylation of Akt and GSK3β compared with control group (P 〉0.05).Pretreatment with 10-7 mol/L testosterone for 36 h followed by insulin stimulation and restimulation after 6 h interval obviously decreased the phosphorylation of Akt and GSK3β (P 〈 0.05).Conclusion Androgen signaling may contribute to insulin resistance in liver cells.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第46期3703-3707,共5页 National Medical Journal of China
关键词 睾酮 胰岛素 HEPG2细胞 多囊卵巢综合征 C57BL 6 Testosterone Insulin Hep G2 cells Polycystic ovary syndrome C57BL/6
  • 相关文献

参考文献17

  • 1Torrens JI, Sutton-Tyrrell K, Zhao X, et al. Relative androgenexcess during the menopausal transition predicts incident nmtabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause, 2009, 16:257-264.
  • 2Hong D, Kim YS, Son ES, et al. Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men. Maturitas. 2013. 74,148-153.
  • 3陈敏,徐雯,苏椿琳,林金芳.睾酮的快速非基因组效应对3T3-L1脂肪细胞胰岛素敏感性的影响[J].中华医学杂志,2008,88(21):1488-1492. 被引量:5
  • 4陈鑫,李昕,黄海艳,李希,林金芳.睾酮对胰岛素敏感细胞胰岛素受体底物1和葡萄糖转运载体4表达的影响[J].中华医学杂志,2006,86(21):1474-1477. 被引量:7
  • 5Gmlgale MF, Miele L, Lanzone A, et al. Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. Clin Endocrinol ( Oxf), 2011, 75:520-527.
  • 6Karoli R, Fatima J, Chandra A, et al. Prevalence of hepatic steatosis in women with polycystic ovary syndrome. J Hum Reprod Sci, 2013, 6:9-14.
  • 7Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism, 1988, 37:15-21.
  • 8Consoli A, Nurjhan N, Capani F, et al. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes, 1989, 38:550-557.
  • 9Kim SP, Ellmerer M, Van Citters GW, et al. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes, 2003, 52:2453-2460.
  • 10Petruzzelli M, Lo Sasso G, Portineasa P, et al. Targeting the liver in the metabolic syndrome: evidence from animal models. Curr Pharm Des, 2007, 13:2199-2207.

二级参考文献36

  • 1卢慧玲,王宏伟,林汉华.促酰化蛋白诱导3T3-F442A前脂肪细胞分化的研究[J].中国病理生理杂志,2005,21(2):243-246. 被引量:4
  • 2李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:140
  • 3陈鑫,李昕,黄海艳,李希,林金芳.睾酮对胰岛素敏感细胞胰岛素受体底物1和葡萄糖转运载体4表达的影响[J].中华医学杂志,2006,86(21):1474-1477. 被引量:7
  • 4吴静,王宏伟,温宇,胡秀芬.性激素对3T3-L1前脂肪细胞和脂肪细胞胰岛素敏感性的影响[J].基础医学与临床,2006,26(9):980-983. 被引量:4
  • 5Golden SH, Ding J, Szklo M, et al. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol, 2004, 160:540-548.
  • 6Beloosesky R, Gold R, Amsterdam A, et al. Induction of polycystic ovary by testosterone in immature female rats : Modulation of apoptosis and attenuation of glucose/insulin ratio. Int J Mol Med, 2004, 14: 207-215.
  • 7Xita N, Tsatsoulis A. Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab, 2006, 91:1660-1666.
  • 8Dunaif A, Xia J, Tang Z, et al. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle, a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest, 1995, 96: 801-810.
  • 9de Alvaro C, Teruel T, Lorenzo M, et al. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem, 2004, 279:17070-17078.
  • 10Nguyen MT, Chi NW, Olefsky JM, et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem, 2005, 280: 35361-35371.

共引文献81

同被引文献53

  • 1陈正琼,成娅.胎盘激素与妊娠期糖尿病[J].重庆医学,2005,34(1):58-60. 被引量:4
  • 2陈正琼,成娅,陈浩波,林桂兰.妊娠期糖耐量异常患者血清E2、P、PRL水平变化及其与瘦素水平的关系[J].重庆医学,2006,35(6):528-529. 被引量:8
  • 3沈春芳,洪洁,张翼飞,顾卫琼,王卫庆,李小英,王敏敏,喇端端,侍庆,宁光.妊娠糖尿病患者胰岛素抵抗与血清C反应蛋白水平的相关性研究[J].内科理论与实践,2008,3(1):37-40. 被引量:13
  • 4RidkerPM.C-reactive protein and the prediction of cardiovacular events among those at intermediate risk:moving an inflammatory hypothesis toward consensus[J]. J Am Coll Cardiol,2007,49(21): 2129-2138.
  • 5GonzalezF, MiniumJ, RoteNS, et al. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia[J]. Metabolism,2006, 55(2): 271-276.DOI: 10.1016/j.metabol.2005.08.022.
  • 6SamyN, HashimM, SayedM, et al. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index[J].Dis Marker ,2009,26(4): 163-170 . DOI: 10.3233/DMA-2009-0627.
  • 7YangY, QiaoJ, LiR,et al. Is interleukin-18 associated with polycystic ovary syndrome[J].Repro Biol Endocrinol,2011,9(1): 7-11. DOI: 10.1186/1477-7827-9-7.
  • 8GlintborgD, AndersenM, RichelsenB,et al.Plasma monocyte chemoattractant protein-1(MCP-1) and macrophage inflammatory ptotein-1 alpha are increased in patients with polycystic ovary syndrome and associated with adiposity,but unaffected by pioglitazone treatment[J].Clin Endocrinol,2009,71(5): 652-658. DOI: 10.1111/j.1365-2265.2009.03523.x.
  • 9JakubowskaJ, Bohdanowicz-PawlakA, MilewiczA. The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman—preliminary report[J].Przgl Lek,2007,64(2): 70-73.
  • 10AlemzadehR, KichlerJ, CalhounM. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome[J]. Europe J Endocrinol, 2010, 162(6): 1093-1099. DOI: 10.1530/EJE-10-0205.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部